Search Results 2651-2660 of 12846 for immunosuppressant drugs
CHICAGO — Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic ...
"This trial provided a unique opportunity to test a new immunotherapy drug in patients who have localized prostate cancer. They don't have metastatic disease ...
The genetic component of onset and treatment of alcohol, drug and other addictions; Treatment for addiction, including anti-craving medicines. Read more about ...
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...
The purpose of this study is to measure patient out-of-pocket outpatient medication cost for patients without prescription drug insurance coverage after ...
A Mayo Clinic nanotherapy crossed the blood-brain barrier in laboratory models, sending cancer drugs directly to GBM tumors. The therapy boosted the tumors ...
Genetic Variations May Identify Best Candidates for Preventive Breast Cancer Drugs ... drugs for prevention.” The study is published in the journal Cancer ...
The purpose of this study is to investigate the effect of Avapritinib on the pharmacokinetics of Midazolam in patients with unresectable or metastatic ...
Schimmenti is working to extend genomics medicine across all specialties at Mayo Clinic. “Our clinical geneticists and genetic counselors are collaborating with ...
Biological therapies, such as lenalidomide, may stimulate or suppress the immune system in different ways and stop cancer cells from growing. Drugs used in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.